Four year immunogenicity of the RTS, S/AS02 (A) malaria vaccine in Mozambican children during a phase IIb trial
Vaccine; 29 (35), 2011
Previous studies with the malaria vaccine RTS,S/AS02A in young children in a malaria endemic area of Mozambique have shown it to have a promising safety profile and to reduce the risk of Plasmodium falciparum infection and disease. In this study, we assessed the antibody responses to the P. falciparum an...